These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7516367)

  • 1. [Epidemiological aspects of benign prostatic hypertrophy].
    Valenti M; Necozione S; Di Orio F
    J Urol (Paris); 1993; 99(6):283-7. PubMed ID: 7516367
    [No Abstract]   [Full Text] [Related]  

  • 2. New insights into the epidemiology and natural history of benign prostatic hyperplasia.
    Boyle P
    Prog Clin Biol Res; 1994; 386():3-18. PubMed ID: 7528398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cancer of the prostate. 1. Epidemiology].
    Mottet Auselo N; Costa P; Le Pellec L; Louis JF; Navratil H
    Prog Urol; 1995 Feb; 5(1):31-7. PubMed ID: 7536526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China.
    Gu F
    Chin Med J (Engl); 2000 Apr; 113(4):299-302. PubMed ID: 11775222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence of benign prostatic hyperplasia and hepatic cirrhosis].
    Toppler S; Bertschinger P; Koch J; Vetter W
    Praxis (Bern 1994); 1999 Sep; 88(37):1467-74. PubMed ID: 10522457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the evaluation and treatment of benign prostatic hypertrophy].
    Wabrosch G; Vanik M
    Orv Hetil; 1993 Oct; 134(44):2411-6. PubMed ID: 7694220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of benign prostatic hyperplasia: risk factors and concomitance with hypertension.
    Boyle P
    Br J Clin Pract Suppl; 1994 May; 74():18-22. PubMed ID: 7519437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of benign hypertrophy of the prostate in Turkish men hospitalized in urology].
    Oztürk A; Serel TA; Kosar A; Kecelioglu M
    Prog Urol; 2000 Sep; 10(4):568-70. PubMed ID: 11064898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and pathological characteristics of prostate cancer in Italy: a contribution to the screening debate.
    Picone GM; Pizzi C; Quartuccio A; Scognamiglio G; Tauchmanova L; Di Maio M; Cifarelli P; Contegiacomo A
    Cancer Detect Prev; 2006; 30(5):455-8. PubMed ID: 17067751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Benign hypertrophy of the prostate (BHP) in France: a challenge in organization of care].
    Costa P
    Ann Urol (Paris); 2006 Mar; 40 Spec No 1():1-3. PubMed ID: 16649581
    [No Abstract]   [Full Text] [Related]  

  • 14. Genital and urinary tract diseases and prostate cancer risk.
    Pelucchi C; Talamini R; Negri E; Franceschi S; La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):254-7. PubMed ID: 16679869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostate cancer--incidence and risk factors].
    Brasso K
    Ugeskr Laeger; 2007 May; 169(20):1883-6. PubMed ID: 17553361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The frequency of surgery of benign prostatic hypertrophy].
    Janin P; Haillot O; Boutin JM; Lesourd B; Hubert B; Lanson Y
    Prog Urol; 1995 Sep; 5(4):515-21. PubMed ID: 7581501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the prevalence of benign prostatic hyperplasia in China.
    Gu F
    Chin Med J (Engl); 1997 Mar; 110(3):163-6. PubMed ID: 9594331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
    Kristal AR; Arnold KB; Schenk JM; Neuhouser ML; Weiss N; Goodman P; Antvelink CM; Penson DF; Thompson IM
    J Urol; 2007 Apr; 177(4):1395-400; quiz 1591. PubMed ID: 17382740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hyperplasia: a review of its histogenesis and natural history.
    Oesterling JE
    Prostate Suppl; 1996; 6():67-73. PubMed ID: 8630233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The current approach to the management of benign hypertrophy of the prostate].
    Abbou CC; Salomon L; Chopin D; Ravery V; Haillot O
    Ann Urol (Paris); 1996; 30(6-7):294-301; discussion 302-10. PubMed ID: 9092383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.